Mark Shapiro

Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study

Anjali S. Advani, Bertrand Coiffier, Myron S. Czuczman et al. · Journal of Clinical Oncology · 2010 · 329 citations · Full text

Novel Immunoconjugate, Immunology, Pharmacotherapy +19

Predictors of Major Morbidity and Mortality After Pneumonectomy Utilizing The Society for Thoracic Surgeons General Thoracic Surgery Database

Mark Shapiro, Cameron D. Wright, Cynthia Chin et al. · The Annals of Thoracic Surgery · 2010 · 235 citations

Pneumothorax, Patient Safety, Postoperative Consideration +8

Thoracoscopic segmentectomy compares favorably with thoracoscopic lobectomy for patients with small stage I lung cancer

Mark Shapiro, Todd S. Weiser, Juan P. Wisnivesky et al. · Journal of Thoracic and Cardiovascular Surgery · 2009 · 169 citations · Full text

Interventional Pulmonology, Medicine, Bronchial Neoplasm +9

Drug-Related Pneumonitis in Patients With Advanced Renal Cell Carcinoma Treated With Temsirolimus

Pablo Maroto, Gary R. Hudes, Janice P. Dutcher et al. · Journal of Clinical Oncology · 2011 · 107 citations · Full text

Long‐term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome‐positive leukemias treated with bosutinib

Jörge E. Cortes, H. Jean Khoury, Hagop M. Kantarjian et al. · American Journal of Hematology · 2016 · 94 citations · Full text

Tyrosine Kinase Inhibitor, Hematological Malignancy, Oncology +14